CIRCLE-Seq: A highly sensitive in vitro screen for genome-wide CRISPR-cas9 nuclease off-targets

Tsai, Shengdar Q, Nguyen, Nhu T, Malagon-Lopez, Jose, Topkar, Ved V, Aryee, Martin J, Joung, J Keith·2017·Nature Methods
DOI 10.1038/nmeth.4278

Cited by (816)

Items 401–500 of 816

  1. CrisPR/CRIS systems are highly effective and useful for genomic manipulation. Despite this, cardiac treatment remains difficult due to existing genome editing and delivery processes.
    Moataz Dowaidar · 2021
  2. In vivo application of base and prime editing to treat inherited retinal diseases
    Dong Hyun Jo, Sangsu Bae, Seokjoong Kim, Jin‐Soo Kim, Jeong Hun Kim · 2022 · Progress in Retinal and Eye Research
  3. Delivery challenges for CRISPR—Cas9 genome editing for Duchenne muscular dystrophy
    Made Harumi Padmaswari, Shilpi Agrawal, Mary S. Jia, Allie Ivy, Daniel A. Maxenberger, Landon A. Burcham, Christopher E. Nelson · 2023 · Biophysics Reviews
  4. Clonally Selected Lines After CRISPR-Cas Editing Are Not Isogenic
    Arijit Panda, Milovan Šuvakov, Jessica Mariani, Kristen L. Drucker, Yohan Park, Yeongjun Jang, Thomas M. Kollmeyer, Gobinda Sarkar, Taejeong Bae, Ji‐Eun Kim et al. · 2023 · The CRISPR Journal
  5. Molecular and functional correction of a deep intronic splicing mutation in CFTR by CRISPR-Cas9 gene editing
    Amy J. Walker, Carina Graham, Miriam Greenwood, Maximillian N. J. Woodall, Ruhina Maeshima, Michelle O’Hara-Wright, David J. Sanz, Ileana Guerrini, Ahmad M. Aldossary, Christopher O’Callaghan et al. · 2023 · Molecular Therapy — Methods & Clinical Development
  6. A simplified G-CSF–free procedure allows for in vivo HSC gene therapy of sickle cell disease in a mouse model
    Chang Long Li, Anna Kate Anderson, Peter Ruminski, Michael P. Rettig, Darja Karpova, Hans‐Peter Kiem, John F. DiPersio, André Lieber · 2024 · Blood Advances
  7. Aspects of Gene Therapy Products Using Current Genome-Editing Technology in Japan
    Teruhide Yamaguchi, Eriko Uchida, Takashi Okada, Keiya Ozawa, Masafumi Onodera, Akihiro Kume, Takashi Shimada, Satoru Takahashi, Kenzaburo Tani, Yasutomo Nasu et al. · 2020 · Human Gene Therapy
  8. Designing Safer CRISPR/Cas9 Therapeutics for HIV: Defining Factors That Regulate and Technologies Used to Detect Off-Target Editing
    Neil T. Sullivan, Alexander G. Allen, Andrew Atkins, Cheng-Han Chung, Will Dampier, Michael R. Nonnemacher, Brian L. Wigdahl · 2020 · Frontiers in Microbiology
  9. Prediction of Human Immunodeficiency Virus Type 1 Subtype-Specific Off-Target Effects Arising from CRISPR-Cas9 Gene Editing Therapy
    Robert W. Link, Michael R. Nonnemacher, Brian L. Wigdahl, Will Dampier · 2018 · The CRISPR Journal
  10. Haplotyping by CRISPR-mediated DNA circularization (CRISPR-hapC) broadens allele-specific gene editing
    Jiaying Yu, Xi Xiang, Jinrong Huang, Xue Liang, Xiaoguang Pan, Zhanying Dong, Trine Skov Petersen, Kunli Qu, Ling Mei Yang, Xiaoying Zhao et al. · 2019 · Nucleic Acids Research
  11. Treating Hearing Loss: From Cochlear Implantation to Gene Therapy
    Fan‐Gang Zeng, Jieyu Qi, Chen‐Chi Wu, Yilai Shu, Renjie Chai · 2025 · Advanced Science
  12. AAV-mediated in vivo genome editing in vascular endothelial cells
    Wenyi Wu, Yanhui Yang, Fei Yao, Lijun Dong, Xiaobo Xia, Shaochong Zhang, Hetian Lei · 2020 · Methods
  13. Overcoming CRISPR-Cas9 off-target prediction hurdles: A novel approach with ESB rebalancing strategy and CRISPR-MCA model
    Yanpeng Yang, Yanyi Zheng, Quan Zou, Jian Li, Hailin Feng · 2024 · PLoS Computational Biology
  14. Non-viral vectors for chimeric antigen receptor immunotherapy
    Sandy Tretbar, Joel G. Rurik, Even Holth Rustad, Duran Sürün, Ulrike Koehl, Johanna Olweus, Frank Buchholz, Zoltán Ivics, Stephan Fricke, Ulrich Blache · 2024 · Nature Reviews Methods Primers
  15. Advancing fish disease research through CRISPR-Cas genome editing: Recent developments and future perspectives
    Huria Marnis, Khairul Syahputra · 2025 · Fish & Shellfish Immunology
  16. Emerging Technologies for Genome-Wide Profiling of DNA Breakage
    Matthew J. Rybin, Melina Ramic, Natalie R. Ricciardi, Philipp Kapranov, Claes Wahlestedt, Zane R. Zeier · 2021 · Frontiers in Genetics
  17. Genotyping-by-Sequencing in Vigna unguiculata Landraces and Its Utility for Assessing Taxonomic Relationships
    Diana Lucia Zuluaga, Lucia Lioi, Chiara Delvento, Stefano Pavan, Gabriella Sonnante · 2021 · Plants
  18. Gene editing & stem cells
    Patrick T. Harrison, Nils Hoppe, Ulrich Martin · 2017 · Journal of Cystic Fibrosis
  19. Refining CRISPR-based genome and epigenome editing off-targets
    Yonglun Luo · 2019 · Cell Biology and Toxicology
  20. Frequent, context-dependent effects of human genetic variation on Cas9 activity revealed by population-scale GUIDE-seq-2 and deep combinatorial CHANCE-seq profiling
    Ashley R. Flory, Cícera Regina Lazzarotto, Yichao Li, Jacqueline Chyr, Muyu Yang, Varun Katta, Elizabeth Urbina, GaHyun Lee, Rachael K. Wood, Azusa Matsubara et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  21. Deep Learning Based Models for CRISPR/Cas Off‐Target Prediction
    Mingming Cao, Alexander Brennan, Ciaran M. Lee, So‐Hyun Park, Gang Bao · 2025 · Small Methods
  22. Preventing secondary primary malignancies (SPMs) in CAR-T cell therapy through site-specific transgene integration into genomic safe harbors (GSHs)
    Pooria Safarzadeh Kozani, Pouya Safarzadeh Kozani · 2025 · Journal of Translational Medicine
  23. Non-Viral CRISPR carriers: transient delivery with lasting effects
    Maria Lummerstorfer, Ulrich Lächelt · 2026 · Drug Delivery
  24. Principles and Applications of CRISPR Toolkit in Virus Manipulation, Diagnosis, and Virus-Host Interactions
    Saleh Jamehdor, Sara Pajouhanfar‎, Sadaf Saba, Georges Uzan, Ali Teimoori, Sina Naserian · 2022 · Cells
  25. Induction of local immunosuppression in allogeneic cell transplantation by cell-type-specific expression of PD-L1 and CTLA4Ig
    Wenliang Zhu, Mengqi Li, Jun Zou, Da Zhang, Minghui Fang, Yun Sun, Can Li, Mingming Tang, Yu–Kai Wang, Qi Zhou et al. · 2023 · Stem Cell Reports
  26. Non-clinical safety assessment of novel drug modalities: Genome safety perspectives on viral-, nuclease- and nucleotide-based gene therapies
    Myriam Lemmens, Lena Dorsheimer, Andreas Zeller, Yasmin Dietz · 2024 · Mutation Research/Genetic Toxicology and Environmental Mutagenesis
  27. Systematic empirical evaluation of individual base editing targets: Validating therapeutic targets in USH2A and comparison of methods
    Yuki Tachida, Kannan Vrindavan Manian, Rossano M. Butcher, Jonathan Ma Levy, Nachiket D. Pendse, Erin Hennessey, David R. Liu, Eric A. Pierce, Qin Liu, Jason Comander · 2025 · Molecular Therapy
  28. PAM-adjacent DNA flexibility tunes CRISPR-Cas12a off-target binding
    Aleiqué Allen, Brendon H Cooper, Jaideep K. Singh, Remo Rohs, Peter Zhifeng Qin · 2025 · Scientific Reports
  29. Multiplex base editing to protect from CD33 directed drugs for immune and gene therapy
    Florence Borot, Olivier Humbert, Jeffrey T. Ehmsen, Emily Fields, Sajeev Kohli, Stefan Radtke, Kyle Swing, Dnyanada Pande, Mark Enstrom, George S. Laszlo et al. · 2025 · Nature Communications
  30. The Gene Sculpt Suite: a set of tools for genome editing
    Carla M. Mann, Gabriel Martínez‐Gálvez, Jordan M. Welker, Wesley A. Wierson, Hirotaka Ata, Maira P. Almeida, Karl J. Clark, Jeffrey J. Essner, Maura A. McGrail, Stephen Carl Ekker et al. · 2019 · Nucleic Acids Research
  31. Disease modeling and stem cell immunoengineering in regenerative medicine using CRISPR/Cas9 systems
    Ainsley Mike Antao, Janardhan Keshav Karapurkar, Dong Ryul Lee, Kye-Seong Kim, Suresh Ramakrishna · 2020 · Computational and Structural Biotechnology Journal
  32. CRISPR-Based Approaches for Efficient and Accurate Detection of SARS-CoV-2
    Wancun Zhang, Kangbo Liu, Pin Zhang, Weyland Cheng, Linfei Li, Fan Zhang, Zhidan Yu, Lifeng Li, Xianwei Zhang · 2020 · Laboratory Medicine
  33. Characterizing genes associated with cancer using the CRISPR/Cas9 system: A systematic review of genes and methodological approaches
    Fernando Gonzalez-Salinas, Claudia Martínez-Amador, Víctor Treviño · 2022 · Gene
  34. Technical considerations towards commercialization of porcine respiratory and reproductive syndrome (PRRS) virus resistant pigs
    A. Mark Cigan, Pieter W. Knap · 2022 · CABI Agriculture and Bioscience
  35. Gene editing as a promising approach for respiratory diseases
    Yichun Bai, Yang Liu, Zhenlei Su, Yana Ma, Chonghua Ren, Runzhen Zhao, Hong‐Long Ji · 2018 · Journal of Medical Genetics
  36. Unexpectedly High Levels of Inverted Re-Insertions Using Paired sgRNAs for Genomic Deletions
    Joseph Blayney, Evangeline M. Foster, Marta Jagielowicz, Mira Kreuzer, Matteo Morotti, Katharina Reglinski, Julie Huiyuan Xiao, Philip Hublitz · 2020 · Methods and Protocols
  37. Integrated design, execution, and analysis of arrayed and pooled CRISPR genome editing experiments
    Matthew C. Canver, Maximilian Haeussler, Daniel E. Bauer, Stuart H. Orkin, Neville E. Sanjana, Ophir Shalem, Guo‐Cheng Yuan, Feng Zhang, Jean‐Paul Concordet, Luca Pinello · 2017 · bioRxiv (Cold Spring Harbor Laboratory)
  38. DENT-seq for genome-wide strand-specific identification of DNA single-strand break sites with single-nucleotide resolution
    Joshua J. Elacqua, Navpreet Ranu, Sarah E. DiIorio, Paul C. Blainey · 2020 · Genome Research
  39. Measurement and clinical interpretation of CRISPR off-targets
    Ariella Angelini Stewart, Rebecca C. Ahrens‐Nicklas, Shengdar Q. Tsai, Kiran Musunuru, Petros Giannikopoulos, Claire Dudley Clelland · 2025 · Nature Genetics
  40. AI-driven advances in plant biotechnology: sharpening the edge of plant tissue culture and genome editing
    Muralikrishna Narra, Anamika Ray, Brittany Polley, Hui Yang, Pankaj Bhowmik · 2025 · Frontiers in Plant Science
  41. Monitoring biological effects of somatic cell genome editing
    Benjamin Freedman, Jeff W. M. Bulte, Bruce R. Conklin, Luke M. Judge, Melinda R. Dwinell, Aron M. Geurts, Madeleine J. Sitton, Vineet Mahajan, Samira Kiani, Charles A. Gersbach et al. · 2026 · Nature Reviews Genetics
  42. A cleavage rule for selection of increased-fidelity SpCas9 variants with high efficiency and no detectable off-targets
    Péter István Kulcsár, András Tálas, Zoltán Ligeti, Eszter Tóth, Zsófia Rakvács, Zsuzsa Bartos, Sarah Laura Krausz, Ágnes Welker, Vanessza Laura Végi, Krisztina Huszár et al. · 2023 · Nature Communications
  43. OliTag-seq enhances in cellulo detection of CRISPR-Cas9 off-targets
    Zhi-Xue Yang, Dong-Hao Deng, Zhu-Ying Gao, Zhi-Kang Zhang, Ya-Wen Fu, Wei Wen, Feng Zhang, Xiang Li, Huayu Li, Jianping Zhang et al. · 2024 · Communications Biology
  44. Machine learning and deep learning for genomic data: a data-centric approach to CRISPR/Cas9 gene editing
    Shehla Rafiq, Muzafar Ahmad Macha, Assif Assad · 2025 · International Journal of Data Science and Analytics
  45. Recent developments with advancing gene therapy to treat chronic infection with hepatitis B virus
    Mohube Betty Maepa, Ridhwaanah Jacobs, Fiona T. van den Berg, Patrick B. Arbuthnot · 2020 · Current Opinion in HIV and AIDS
  46. Element coding based accurate evaluation of CRISPR/Cas9 initial cleavage
    Jianyu Hu, Rui Liu, Jing Zhou, Yi Lv · 2021 · Chemical Science
  47. Full-Length Dystrophin Restoration via Targeted Exon Addition in DMD-Patient Specific iPSCs and Cardiomyocytes
    Rou Xiao, Miaojin Zhou, Peiyun Wang, Baitao Zeng, Lingqian Wu, Zhiqing Hu, Desheng Liang · 2022 · International Journal of Molecular Sciences
  48. CRISPR-detector: fast and accurate detection, visualization, and annotation of genome-wide mutations induced by genome editing events
    Lei Huang, Dan Wang, Haodong Chen, Jinnan Hu, Xuechen Dai, Chuan Liu, Anduo Li, Xuechun Shen, Qi Chen, Hai‐Xi Sun et al. · 2023 · Journal of genetics and genomics/Journal of Genetics and Genomics
  49. Comprehensive Analysis of CRISPR/Cas9-Mediated Mutagenesis in Arabidopsis thaliana by Genome-Wide Sequencing
    W. Xu, Wei Fu, Pengyu Zhu, Zhihong Li, Chenguang Wang, Chaonan Wang, Yongjiang Zhang, Shuifang Zhu · 2019 · International Journal of Molecular Sciences
  50. Evaluation of the CRISPR/Cas9 Genetic Constructs in Efficient Disruption of Porcine Genes for Xenotransplantation Purposes Along with an Assessment of the Off-Target Mutation Formation
    Natalia Ryczek, Magdalena Hryhorowicz, Daniel Lipiński, Joanna Zeyland, Ryszard Słomski · 2020 · Genes
  51. Critical cancer vulnerabilities identified by unbiased CRISPR/Cas9 screens inform on efficient cancer Immunotherapy
    Margaret A. Potts, Jackson A. McDonald, Kate D Sutherland, Marco J. Herold · 2020 · European Journal of Immunology
  52. The origin of unwanted editing byproducts in gene editing
    Jianhang Yin, Jiazhi Hu · 2022 · Acta Biochimica et Biophysica Sinica
  53. Base editing generates substantial off-target single nucleotide variants
    Erwei Zuo, Yidi Sun, Wei Wu, Tanglong Yuan, Wenqin Ying, Lars Michael Steinmetz, Yixue Li, Hui Yang · 2018 · bioRxiv (Cold Spring Harbor Laboratory)
  54. A Practical Guide to Genome Editing Using Targeted Nuclease Technologies
    Shaina N. Porter, Rachel M. Levine, Shondra M. Pruett‐Miller · 2019 · Comprehensive physiology
  55. Therapeutic adenine base editing corrects nonsense mutation and improves visual function in a mouse model of Leber congenital amaurosis
    Dong Hyun Jo, Hyeon‐Ki Jang, Chang Sik Cho, Jun Hee Han, Gahee Ryu, Youngri Jung, Sangsu Bae, Jeong Hun Kim · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  56. Current trends in gene therapy to treat inherited disorders of the brain
    Żaneta Matuszek, Brandon L. Brown, Carolyn M. Yrigollen, Megan S. Keiser, Beverly L. Davidson · 2025 · Molecular Therapy
  57. Evaluation and prediction of guide RNA activities in genome-editing tools
    Hui Kwon Kim, Seokjoong Kim · 2025 · Nature Reviews Bioengineering
  58. Topology‐Engineered Guide RNAs for Programmable Control of CRISPR/Cas Activity
    Liang Cheng · 2025 · Angewandte Chemie International Edition
  59. The Evolution of Nucleic Acid–Based Diagnosis Methods from the (pre-)CRISPR to CRISPR era and the Associated Machine/Deep Learning Approaches in Relevant RNA Design
    Shruti Sarika Chakraborty, Jayati Ray Dutta, Ramakrishnan Ganesan, Péter Mináry · 2024 · Methods in molecular biology
  60. Precise measurement of CRISPR genome editing outcomes through single-cell DNA sequencing
    Nechama Kalter, Saurabh Gulati, Michael Rosenberg, Qawer Ayaz, Joanne Nguyen, Shu Wang, Benjamin Schroeder, Chieh-Yuan Li, Ayal Hendel · 2025 · Molecular Therapy — Methods & Clinical Development
  61. Charting the development and engineering of CRISPR base editors: lessons and inspirations
    Siyuan Zou, Yihong Sun, Weixin Tang · 2025 · Cell chemical biology
  62. Advances in Therapeutic Applications of CRISPR Genome Editing for Spinal Pain Management
    Chan Young Kang, Kyung Wook Been, Mi Ra Kang, Myung Su Choi, Rae Hee Kang, Junseok W. Hur, Junho K. Hur · 2025 · Neurospine
  63. Analysis of Off-Target Mutations in CRISPR-Edited Rice Plants Using Whole-Genome Sequencing
    Guanqing Liu, Yiping Qi, Tao Zhang · 2021 · Methods in molecular biology
  64. CasKAS: direct profiling of genome-wide dCas9 and Cas9 specificity using ssDNA mapping
    Georgi K. Marinov, Samuel H. Kim, S. Tansu Bagdatli, Soon Il Higashino, Alexandro E. Trevino, Josh Tycko, Tong Wu, Lacramioara Bintu, Michael Cory Bassik, Chuan He et al. · 2023 · Genome biology
  65. Base editing corrects the common Salla disease SLC17A5 c.115C>T variant
    Jerry F. Harb, Chloe L. Christensen, Shih‐hsin Kan, Allisandra K. Rha, Perla Andrade-Heckman, Laura Pollard, Richard Steet, Jeffrey Y. Huang, Raymond Wang · 2023 · Molecular Therapy — Nucleic Acids
  66. TEG-Seq: An Ion Torrent-Adapted NGS Workflow for in Cellulo Mapping of CRISPR Specificity
    Pei‐Zhong Tang, Ding Bo, Lansha Peng, Vadim Mozhayskiy, Jason Potter, Jonathan D. Chesnut · 2018 · BioTechniques
  67. Improved HTGTS for CRISPR/Cas9 Off-target Detection
    Jianhang Yin, Mengzhu Liu, Yang Liu, Jiazhi Hu · 2019 · BIO-PROTOCOL
  68. Utilization of CRISPR/Cas9 gene editing in cellular therapies for lymphoid malignancies
    Maryam Mehravar, Elham Roshandel, Maryam Salimi, Rouzbeh Chegeni, Majid Gholizadeh, Mohammad Hossein Mohammadi, Abbas Hajifathali · 2020 · Immunology Letters
  69. Advances in gene editing strategies for epidermolysis bullosa
    Thomas Köcher, Ulrich Koller · 2021 · Progress in molecular biology and translational science
  70. CRISPR/Cas-based Human T cell Engineering: Basic Research and Clinical Application
    Bettina E. Bernard, Emmanuelle Landmann, Lukas T. Jeker, Kathrin Schumann · 2022 · Immunology Letters
  71. A scalable, GMP-compatible, autologous organotypic cell therapy for Dystrophic Epidermolysis Bullosa
    Gernot Neumayer, Jessica L. Torkelson, Shengdi Li, Kelly McCarthy, Hanson Hui Zhen, Madhuri Vangipuram, J. Jackow, Avina Rami, Corey S. Hansen, Zongyou Guo et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  72. CHANGE-seq-BE enables simultaneously sensitive and unbiased in vitro profiling of base editor genome-wide activity
    Cícera Regina Lazzarotto, Varun Katta, Yichao Li, Elizabeth Urbina, GaHyun Lee, Shengdar Q. Tsai · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  73. Complex structural variation is prevalent and highly pathogenic in pediatric solid tumors
    Ianthe A. E. M. van Belzen, Marc C van Tuil, Shashi Badloe, Alex Janse, Eugène T.P. Verwiel, Marcel Santoso, Sam de Vos, John L. Baker-Hernandez, Hindrik H. D. Kerstens, Nienke Solleveld‐Westerink et al. · 2024 · Cell Genomics
  74. CRISPR-MFH: A Lightweight Hybrid Deep Learning Framework with Multi-Feature Encoding for Improved CRISPR-Cas9 Off-Target Prediction
    Yanyi Zheng, Quan Zou, Jian Li, Yanpeng Yang · 2025 · Genes
  75. The Genetic Blueprint of Obesity: From Pathogenesis to Novel Therapies
    Gašper Tonin, Stjepan Eržen, Zala Mlinarič, Dubravka Jurišić‐Eržen, Simon Horvat, Tanja Kunej, Jasna Klen · 2025 · Obesity Reviews
  76. Delivery Methods, Resources and Design Tools in CRISPR/Cas
    Muhammad Aamir Aslam, Masooma Hammad, Aftab Ahmad, Josef Altenbuchner, Hazrat Ali · 2021 · Springer eBooks
  77. Highly Efficient Ex Vivo Correction of COL7A1 through Ribonucleoprotein-Based CRISPR/Cas9 and Homology-Directed Repair to Treat Recessive Dystrophic Epidermolysis Bullosa
    Camille Berthault, Sonia Gaucher, Olivier Gouin, Alain Schmitt, Mei Chen, David T. Woodley, Matthias Titeux, Alain Hovnanian, Araksya Izmiryan · 2023 · Journal of Investigative Dermatology
  78. Increasing the precision of gene editing in vitro, ex vivo, and in vivo
    Katherine P. Mueller, Jared Carlson-Stevermer, Krishanu Saha · 2018 · Current Opinion in Biomedical Engineering
  79. Sequencing data from Massachusetts General Hospital shows Cas9 integration into the genome, highlighting a serious hazard in gene-editing therapeutics
    Sandeep Chakraborty · 2019 · F1000Research
  80. Genome-wide CRISPR screens for the identification of therapeutic targets for cancer treatment
    Vivian Weiwen Xue, Sze Chuen Cesar Wong, William Chi Shing Cho · 2020 · Expert Opinion on Therapeutic Targets
  81. CROP: a CRISPR/Cas9 guide selection program based on mapping guide variants
    Victor Aprilyanto, Redi Aditama, Zulfikar Achmad Tanjung, Condro Utomo, Tony Liwang · 2021 · Scientific Reports
  82. CRISPR/Cas9-mediated genome editing in naïve human embryonic stem cells
    Eva Jacobs, Sharat Warrier, Pieter‐Jan Volders, Eva D’haene, Eva Van Lombergen, Lies Vantomme, Margot Van der Jeught, Björn Heindryckx, Björn Menten, Sarah Vergult · 2017 · Scientific Reports
  83. NmeCas9 is an intrinsically high-fidelity genome editing platform
    Nadia Amrani, Xin D. Gao, Pengpeng Liu, Alireza Edraki, Aamir Mir, Raed Ibraheim, Ankit Gupta, Kanae E. Sasaki, Tong Wu, Paul D. Donohoue et al. · 2017 · bioRxiv (Cold Spring Harbor Laboratory)
  84. LATE–a novel sensitive cell-based assay for the study of CRISPR/Cas9-related long-term adverse treatment effects
    Dawid Głów, Simon Meyer, Irene García Roldán, Lara Akingunsade, Kristoffer Riecken, Boris Fehse · 2021 · Molecular Therapy — Methods & Clinical Development
  85. Treating genetic blood disorders in the era of CRISPR-mediated genome editing
    Alhomidi Almotiri, Ahmed Abogosh, Ali Abdelfattah, Dalya Alowaisy, Neil P. Rodrigues · 2025 · Molecular Therapy
  86. Genome editing strategies for targeted correction of β-globin mutation in sickle cell disease: From bench to bedside
    Henna Butt, Shruti Sathish, Evan London, Taylor Lee Johnson, Khaled Essawi, Alexis Kristine Leonard, John F. Tisdale, Selami Demirci · 2025 · Molecular Therapy
  87. TOPO-seq reveals DNA topology-induced off-target activity by Cas9 and base editors
    Min Duan, Pan Gao, Yi-Zhou Zhang, Yu-Long Hu, Lei Zhou, Zhong-Chen Xu, Hou-Yuan Qiu, Xiaohan Tong, Rui-Jin Ji, Xin-Lin Lei et al. · 2025 · Nature Chemical Biology
  88. Single-dose genome editing therapy rescues auditory and vestibular functions in adult mice with DFNA41 deafness
    Wei Wei, Wenliang Zhu, Stewart Silver, Ariel Miura Armstrong, Fletcher S. Robbins, Arun Prabhu Rameshbabu, Katherina Walz, Yizhou Quan, Wan Du, Yehree Kim et al. · 2025 · Journal of Clinical Investigation
  89. Methods for detecting off-target effects of CRISPR/Cas9
    Yingying Xu, Shengmei Zhou, Lu-Yan Wang, Rong Zhang, Kai Li, Zhiyuan Qian, Xiao Li · 2025 · Biotechnology Advances
  90. Assessing off-target effects in CRISPR/Cas9: challenges and strategies for precision DNA editing
    Abdul Basit, Jianzhong Zhu, Wanglong Zheng · 2026 · Archives of Microbiology
  91. Mechanisms of the Specificity of the CRISPR/Cas9 System in Genome Editing
    Liliya M. Kulishova, Ivan P. Vokhtantsev, D. V. Kim, Dmitry O. Zharkov · 2023 · Molecular Biology
  92. Delivery of gene editing therapeutics
    Bhavesh D. Kevadiya, Farhana S. Islam, Pallavi Deol, Lubaba A. Zaman, Dina A. Mosselhy, Md Ashaduzzaman, Neha Bajwa, Nanda Kishore Routhu, Preet Amol Singh, Shilpa Dawre et al. · 2023 · Nanomedicine Nanotechnology Biology and Medicine
  93. Genome editing for sickle cell disease: still time to correct?
    Giulia Ceglie, Marco Lecis, Gabriele Canciani, Mattia Algeri, Giacomo Frati · 2023 · Frontiers in Pediatrics
  94. CRISPR/Cas9‐Based Safe‐Harbor Gene Editing in Rhesus iPSCs
    Ravi Chandra Yada, John W. Ostrominski, Ilker Tunc, So Gun Hong, Jizhong Zou, Cynthia E. Dunbar · 2017 · Current Protocols in Stem Cell Biology
  95. From Basic Biology to Patient Mutational Spectra of GATA2 Haploinsufficiencies: What Are the Mechanisms, Hurdles, and Prospects of Genome Editing for Treatment
    Cansu Koyunlar, Emma de Pater · 2020 · Frontiers in Genome Editing
  96. Generating CRISPR‐Cas9‐Mediated Null Mutations and Screening Targeting Efficiency in Human Pluripotent Stem Cells
    Oliver J. Bower, Afshan McCarthy, Rebecca A. Lea, Gregorio Alanis‐Lobato, Jasmin Zohren, Claudia Gerri, James M. A. Turner, Kathy K. Niakan · 2021 · Current Protocols
  97. A Machine Learning Approach to Identify the Importance of Novel Features for CRISPR/Cas9 Activity Prediction
    Dhvani Sandip Vora, Yugesh Verma, Durai Sundar · 2022 · Biomolecules
  98. Tracking CRISPR’s Footprints
    Lin Lin, Yonglun Luo · 2019 · Methods in molecular biology
  99. Gene editing in hemophilia: a “CRISPR” choice?
    Steven W. Pipe, Sundar Rajan Selvaraj · 2019 · Blood
  100. Discovering the Genome-Wide Activity of CRISPR-Cas Nucleases
    Shengdar Q. Tsai · 2017 · ACS Chemical Biology